Sign in

CIK 0001984086

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Septerna, Inc.

Sign in to watch
Ticker
SEPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843891440
Phone
+1 650-338-3533
Business address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,017,100
in 4 filings, $5.0M under 10b5-1 plans

Net −$5,017,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Finer Jeffrey Chief Executive Officer Exercise or conversion 10b5-1 +18,500 $2.76 $51K 852,409
2026-11-12 Finer Jeffrey Chief Executive Officer Sale 10b5-1 −5,600 $42.09 $236K 846,809
2026-11-12 Finer Jeffrey Chief Executive Officer Sale 10b5-1 −5,300 $43.10 $228K 841,509
2026-11-12 Finer Jeffrey Chief Executive Officer Sale 10b5-1 −2,800 $44.23 $124K 838,709
2026-11-12 Finer Jeffrey Chief Executive Officer Sale 10b5-1 −2,823 $45.28 $128K 835,886
2026-11-12 Finer Jeffrey Chief Executive Officer Sale 10b5-1 −1,977 $46.16 $91K 833,909
2026-11-12 Finer Jeffrey Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −18,500 378,712
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −6,939 $46.01 $319K 110,481
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −13,201 $47.01 $621K 97,280
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −22,865 $47.78 $1.1M 74,415
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −31,572 $48.70 $1.5M 42,843
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −4,175 $49.65 $207K 38,668
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −2,013 $50.90 $102K 36,655
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −1,055 $51.90 $55K 35,600
2026-10-15 Bhatt Elizabeth President and COO Exercise or conversion 10b5-1 +4,000 $6.81 $27K 178,209
2026-10-15 Bhatt Elizabeth President and COO Sale 10b5-1 −1,094 $36.87 $40K 177,115
2026-10-15 Bhatt Elizabeth President and COO Sale 10b5-1 −2,906 $37.61 $109K 174,209
2026-10-15 Bhatt Elizabeth President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,000 58,230
2026-09-08 Patni Rajiv Chief Medical Officer Grant or award · Stock Option (Right to Buy) +275,000 275,000
2026-09-01 Long Daniel D. SVP, Drug Discovery Exercise or conversion 10b5-1 +3,333 $2.76 $9K 99,745

Page 1 of 8 · 155 trades